The Relative Survival Impact of Guideline-Concordant Clinical Staging and Stage-Appropriate Treatment of Potentially Curable Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

The Relative Survival Impact of Guideline-Concordant Clinical Staging and Stage-Appropriate Treatment of Potentially Curable Non-Small Cell Lung Cancer

Published:2022-07 Issue:1 Volume:162 Page:242-255
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Meadows-Taylor Meghan B.,Faris Nicholas R.,Smeltzer Matthew P.,Ray Meredith A.,Fehnel Carrie,Akinbobola Olawale,Ariganjoye Folabi,Patel Anita,Pacheco Alicia,Mehrotra Anurag,Fox Roy,Optican Robert,Tonkin Keith,Machin James,Wright Jeffrey,Robbins Edward T.,Osarogiagbon Raymond U.

Funder

Association of Community Cancer Centers

Eli Lilly and Company

AstraZeneca

American Cancer Society

Patient-Centered Outcomes Research Institute

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference38 articles.

1. Establishing the diagnosis of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines;Rivera;Chest,2013